Reports that microbial genomics is producing a number of candidate targets for developing new classes of antimicrobial agent. Increased and widespread prevalence of microbial antibiotic resistance; Number of microbial genomes that have been sequenced by researchers worldwide as of December 2001; Possible emergence of alternative therapies that protect the host from comparative genomic strategies.